Volpara Solutions Limited
RELATED CONTENT
Volpara Solutions announced that it has received a new 510(k) clearance from the U.S. Food & Drug Administration (FDA) for Volpara Density Maps.
January 15, 2016 
December 31, 2015 — Volpara Solutions has gone mobile with the first-ever installation of VolparaDensity in a mobile ...
December 31, 2015 
Researchers from Elizabeth Wende Breast Care (EWBC) demonstrated the importance of automated volumetric breast density to improving the performance of mammographic screening programs in two studies presented at the 101st annual Radiological Society of North America (RSNA) meeting.
December 11, 2015 
Volpara Solutions announced that it has received a new 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its VolparaDensity breast imaging software.
November 12, 2015 
September 30, 2015 — Volpara Solutions will be showcasing the latest updates on its breast density and quantitative ...
September 30, 2015 With the increased availability of and reliance on high-dose imaging modalities for rapid and comprehensive diagnosis ...
September 09, 2015 Researchers at the University of Virginia (UVA) Health System have demonstrated that automated volumetric fibroglandular breast density measurement tools are more precise than area-based methods. Results of the study, "Reliability of Automated Breast Density Measurements," recently featured in Radiology, suggest that with lower variability, volumetric breast density is well suited for inclusion in breast cancer risk models. The announcement was made at the Association for Medical Imaging Management (AHRA)'s 43rd annual meeting and exposition, July 19-22 in Las Vegas.
July 21, 2015 
The first randomized trial investigating the additional value of magnetic resonance imaging (MRI) for screening women with dense breasts, is featured in the current issue of Radiology. The article, “MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50–75 Years with Extremely Dense Breasts: The DENSE Trial Study Design,†presents the rationale and design of the DENSE Trial. Run by Carla van Gils, M.D., and Wouter Veldhuis, M.D., from University Medical Center Utrecht (UMCU) in the Netherlands, the trial seeks to determine the effectiveness of screening with mammography and MRI compared to mammography alone in women who have extremely dense breasts.
July 08, 2015 
Volpara Solutions announced the release of VolparaDensity version 3.1 at the Society of Breast Imaging’s SBI/ACR Breast Imaging Symposium in Orlando, Florida, April 25-28.
April 29, 2015 
Volpara Solutions announced the installation of VolparaDensity in Belgium, marking the 31st country where the system has been implemented. New installations were also recently completed in Canada, Turkey, Korea, Japan and the United Kingdom.
April 24, 2015